Study: Despite failures, chemo still promising against dangerous childhood brain cancer, DIPG

Chemotherapy has been so unsuccessful against DIPG that researchers have questioned whether chemotherapy drugs are even able to reach the cancer. University of Colorado Cancer Center study shows, “… medicine does reach DIPG tissue in good quantities that have the potential to be effective against the tumor,” says lead researcher.

Read more

Post-diagnosis disparities drive poorer outcomes for pediatric Black and Hispanic brain cancer patients

Of 1,881 patients under age 19 diagnosed with cancers of the brain and central nervous system between 2000 and 2015, 52 percent of White patients lived five years from diagnosis, whereas only 44 percent of African American patients and 45 percent of Hispanic patients reached a similar milestone.

Read more

$150K Pledge from Om Foundation to Support Pediatric Cancer Research at Rutgers Cancer Institute of New Jersey

A $150,000 pledge from the Om Foundation will aid investigators at Rutgers Cancer Institute of New Jersey in examining a certain type of medication that impacts gene activity in the treatment of a form of pediatric brain cancer.

Read more